A recent Federal Trade Commission (FTC) report highlighted that leading PBMs have significantly inflated pharmacy costs, impacting both employers and employees
Instead, it focuses on daily habits, nutrition targets, behavior change and long-term sustainability
Although its currently approved for type 2 diabetes, its potential for weight loss is generating significant interest
It is provided for education and is not a substitute for professional medical advice
Personalized Treatment Duration Using Genetic Insights The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609) and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Patients with atrial fibrillation who lose weight may see a reduction in stroke risk, potentially affecting long-term anticoagulant strategya conversation your cardiologist should lead